Orgenesis ORGS Stock
Orgenesis Price Chart
Orgenesis ORGS Financial and Trading Overview
| Orgenesis stock price | 0.5 USD |
| Previous Close | 1.33 USD |
| Open | 1.38 USD |
| Bid | 0 USD x 4000 |
| Ask | 0 USD x 1400 |
| Day's Range | 1.28 - 1.38 USD |
| 52 Week Range | 0.98 - 2.64 USD |
| Volume | 19.35K USD |
| Avg. Volume | 42.75K USD |
| Market Cap | 36.84M USD |
| Beta (5Y Monthly) | 0.928873 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.91 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 6 USD |
ORGS Valuation Measures
| Enterprise Value | 89.23M USD |
| Trailing P/E | N/A |
| Forward P/E | 2.1311474 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 1.0274158 |
| Price/Book (mrq) | 1.3091642 |
| Enterprise Value/Revenue | 2.488 |
| Enterprise Value/EBITDA | -16.438 |
Trading Information
Orgenesis Stock Price History
| Beta (5Y Monthly) | 0.928873 |
| 52-Week Change | -35.32% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 2.64 USD |
| 52 Week Low | 0.98 USD |
| 50-Day Moving Average | 1.16 USD |
| 200-Day Moving Average | 1.62 USD |
ORGS Share Statistics
| Avg. Volume (3 month) | 42.75K USD |
| Avg. Daily Volume (10-Days) | 25.55K USD |
| Shares Outstanding | 28.34M |
| Float | 26.36M |
| Short Ratio | 6.29 |
| % Held by Insiders | 11.97% |
| % Held by Institutions | 11.14% |
| Shares Short | 199.1K |
| Short % of Float | 0.70% |
| Short % of Shares Outstanding | 0.69% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:12 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -42.025% |
| Operating Margin (ttm) | -20.94% |
| Gross Margin | 94.39% |
| EBITDA Margin | -15.13% |
Management Effectiveness
| Return on Assets (ttm) | -6.18% |
| Return on Equity (ttm) | -26.40% |
Income Statement
| Revenue (ttm) | 35.86M USD |
| Revenue Per Share (ttm) | 1.41 USD |
| Quarterly Revenue Growth (yoy) | -2.29% |
| Gross Profit (ttm) | 36.03M USD |
| EBITDA | -5428000 USD |
| Net Income Avi to Common (ttm) | -15069000 USD |
| Diluted EPS (ttm) | -0.58 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 2.67M USD |
| Total Cash Per Share (mrq) | 0.09 USD |
| Total Debt (mrq) | 22.57M USD |
| Total Debt/Equity (mrq) | 38.05 USD |
| Current Ratio (mrq) | 3.548 |
| Book Value Per Share (mrq) | 0.993 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -29372000 USD |
| Levered Free Cash Flow (ttm) | -38028000 USD |
Profile of Orgenesis
| Country | United States |
| State | MD |
| City | Germantown |
| Address | 20271 Goldenrod Lane |
| ZIP | 20876 |
| Phone | 480 659 6404 |
| Website | https://www.orgenesis.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 167 |
Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient at their point of care for treatment of the patient. The company was formerly known as Business Outsourcing Service, Inc. and changed its name to Orgenesis Inc. in August 2011. Orgenesis Inc. was incorporated in 2008 and is based in Germantown, Maryland.
Q&A For Orgenesis Stock
What is a current ORGS stock price?
Orgenesis ORGS stock price today per share is 0.5 USD.
How to purchase Orgenesis stock?
You can buy ORGS shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Orgenesis?
The stock symbol or ticker of Orgenesis is ORGS.
Which industry does the Orgenesis company belong to?
The Orgenesis industry is Biotechnology.
How many shares does Orgenesis have in circulation?
The max supply of Orgenesis shares is 33.66M.
What is Orgenesis Price to Earnings Ratio (PE Ratio)?
Orgenesis PE Ratio is now.
What was Orgenesis earnings per share over the trailing 12 months (TTM)?
Orgenesis EPS is -0.91 USD over the trailing 12 months.
Which sector does the Orgenesis company belong to?
The Orgenesis sector is Healthcare.
Orgenesis ORGS included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ Capital Market Composite RCMP | 114.55 USD — |
-2.27
|
— — | 114.09 USD — | 116.72 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
- {{ link.label }} {{link}}